Comparative Outcomes In Transthyretin Amyloid Cardiomyopathy Vs HFpEF

被引：0
|
作者：
Kim, Morris M. [1 ]
Prasad, Mark [1 ]
Burton, Yunwoo [1 ]
Kolseth, Clinton [1 ]
Chandrashekar, Pranav [1 ]
Masri, Ahmad [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
JOURNAL OF CARDIAC FAILURE | 2023年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
345
引用
收藏
页码：690 / 691
页数：2
相关论文
共 50 条
  • [1] Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy
    Ioannou, Adam
    Razvi, Yousuf
    Porcari, Aldostefano
    Rauf, Muhammad U.
    Martinez-Naharro, Ana
    Venneri, Lucia
    Kazi, Salsabeel
    Pasyar, Ali
    Luxhoj, Carina M.
    Petrie, Aviva
    Moody, William
    Steeds, Richard P.
    Sperry, Brett W.
    Witteles, Ronald M.
    Whelan, Carol
    Wechalekar, Ashutosh
    Lachmann, Helen
    Hawkins, Philip N.
    Solomon, Scott D.
    Gillmore, Julian D.
    Fontana, Marianna
    JAMA CARDIOLOGY, 2025, 10 (01) : 50 - 58
  • [2] PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN UNDIFFERENTIATED HFPEF
    Healy, Liam
    Mahon, Niall
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 733 - 733
  • [3] PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN UNDIFFERENTIATED HFPEF
    Healy, L.
    Giblin, G.
    O'Sullivan, D.
    Kavanagh, E.
    Howley, E.
    Tracey, C.
    O'Neill, J.
    Joyce, E.
    O'Connell, M.
    McDaid, A.
    Clarke, A.
    Gray, A.
    Mahon, N.
    HEART, 2022, 108 : A11 - A11
  • [4] Tafamidis Stabilizes Transthyretin and Improves Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy
    Falk, Rodney
    Maurer, Matthew
    Fedson, Savitri
    Judge, Daniel
    Zeldenrust, Steven
    Quyyumi, Arshed
    Pano, Arian
    Packman, Jeff
    Grogan, Donna
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S56 - S56
  • [5] Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes
    Maurer, Mathew S.
    Grogan, Donna R.
    Judge, Daniel P.
    Mundayat, Rajiv
    Packman, Jeff
    Lombardo, Ilise
    Quyyumi, Arshed A.
    Aarts, Janske
    Falk, Rodney H.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 519 - 526
  • [6] Transthyretin amyloid cardiomyopathy
    Famularo, Giuseppe
    Ventroni, Guido
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (02): : E25 - E25
  • [7] Transthyretin amyloid cardiomyopathy
    Garcia-Pavia, Pablo
    Dominguez, Fernando
    Gonzalez-Lopez, Esther
    MEDICINA CLINICA, 2021, 156 (03): : 126 - 134
  • [8] Transthyretin amyloid cardiomyopathy
    Czepluch, Frauke
    INNERE MEDIZIN, 2023, 64 (09): : 823 - 829
  • [9] Comparative assessment of extracellular volume metrics in predicting adverse outcomes in patients with transthyretin amyloid cardiomyopathy
    Kronberger, C.
    Willixhofer, R.
    Ermolaev, N.
    Poledniczek, M.
    Duca, F.
    Rettl, R.
    Binder-Rodriguez, C.
    Mascherbauer, K.
    Dona, C.
    Koschutnik, M.
    Nitsche, C.
    Eslam, R. Badr
    Bergler-Klein, J.
    Kastner, J.
    Kammerlander, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] A simple ATTR-CM score to identify transthyretin amyloid cardiomyopathy burden in HFpEF patients
    Ye, Min
    Liu, Xiao
    Gu, Zhenbang
    Sun, Junyi
    Dong, Yugang
    Chen, Yili
    Liu, Chen
    Wu, Zexuan
    Zhu, Wengen
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
12345